Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 9Phase 4 6Phase 2/3 4Phase 1/2 3Phase 1 2Phase NA 1

Status

Unknown 4Completed 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

NSCLC 1Multiple Myeloma 1Liver Neoplasms 1Leukemia, Large Granular Lymphocytic 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Thalidomide × Clear all
NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

National University Hospital, Singapore

Phase 2/3 Unknown
20 enrolled
Plasma cell

Multiple Myeloma

NCT04453345 2020-07-01

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Institute of Hematology & Blood Diseases Hospital, China

Phase 2/3 Unknown
42 enrolled
Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT02387086 2015-03-12

Gefitinib Combined With Thalidomide to Treat NSCLC

Shaanxi Provincial People's Hospital

Phase 2/3 Unknown
380 enrolled
Thoracic

NSCLC

NCT00728078 2009-02-09

LDT-RFA

Sun Yat-sen University

Phase 2/3 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡